Future successful EDC companies will emerge from those companies who listen to their customers, identify their needs and commit to a progressive Research and Development function. This strategy will deliver innovative products and services to pharma and CROs.
Research and Development is the constant theme in bringing new efficiencies to the management of clinical trials.
The rate of technology change is high and therefore CTEP must continue to evolve to maintain an advantage. CTEP is constantly innovating in response to customer demands and our vision for future success.
Stephen Dorman has spent his working career in the pharmaceutical industry and was formerly managing director of Glaxo in Ireland. He was a board member of the Irish Pharmaceutical Industry Association. Stephen has a deep understanding of the evolving opportunities and challenges facing the life science sector.
Tomás O'Mahoney has over 15 years of international clinical trial experience in Japan, the UK and Ireland. He was European clinical trial project manager with Marion Merrell Dow (now Sanofi-Aventis) and also worked with Boehringer Ingelheim Ltd in Ireland. As operations director, Tomás interprets the operational challenges for your study and makes the EDC practical for each stakeholder.
CTO / Head of Technology
Steve Tee has more than 15 years working in the IT industry in Ireland and abroad with companies as EDS, Syllogic, Perot Systems, Curam and eSpatial. Steve is responsible for technology research, strategy and day-to-day management of the IT team and infrastructure within CTEP.